Trial intelligence / Profile preview

Esomeprazole for asthma with GERD symptoms

NCT00317044Phase 2Completed

Sponsor
AstraZeneca
Start
Apr 2006
Primary completion
Jul 2008
Modality
Small Molecules
Countries
14
01

Overview

A Phase 2 trial of esomeprazole in asthma, sponsored by AstraZeneca. Started Apr 2006; status: completed.

02

Drugs

esomeprazole
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00317044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00317044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call